미국의 비뇨기과 시장 : 규모, 점유율, 동향 분석(2024-2030년) - MedSuite
Urology Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: Urinary Incontinence Devices, Stone Management Devices, and 7 more
상품코드 : 1509744
리서치사 : iData Research Inc.
발행일 : 2024년 04월
페이지 정보 : 영문 537 Pages

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.


한글목차

미국 비뇨기과 시장 규모는 5.7%의 CAGR로 확대되어 2030년에는 65억 달러에 육박할 것으로 예상됩니다.

병원이 외래환자 시설 인수를 계속 확대하고 그룹구매조직(GPO)의 영향력이 커지는 가운데 비뇨기과에서는 진료비 인하가 계속되고 있어 평균판매가격(ASP)이 지속적인 압력에 직면해 향후 시장 성장을 저해할 수 있습니다.

NeoTract의 UroLift(R)는 2013년 미국에서 출시된 이후 전립선비대증(BPH) 치료제로 비뇨기과 의사들 사이에서 빠르게 확산되고 있으며, 유럽, 캐나다, 호주 등 다른 지역에서도 인기를 얻고 있습니다. 2017년 Teleflex가 NeoTract를 인수하면서 Teleflex의 광범위한 판매망을 통해 UroLift(R)의 시장 침투력을 강화했으며, 2021년 9월에는 UroLift Advanced Tissue Control(ATC)(R) 및 UroLift(R) 2 시스템의 출시는 초기 임상적 성공에 기반하여 환자의 안전성을 높이고 물류 부담을 줄이기 위한 것입니다.

이 보고서는 미국의 비뇨기과 시장에 대해 조사했으며, 시장 개요와 함께 부문별 동향, 시장 촉진요인 및 저해요인, 경쟁 시장 점유율 분석, 시장 진입 기업 개요 등의 정보를 전해드립니다.

목차

주요 요약

조사 방법

세계의 비뇨기과 시장에 대한 COVID-19의 영향

질환 개요

제품 평가

미국의 비뇨기과 기기 시장 개요

요실금 기기 시장

결석 관리 기기 시장

BPH 치료 기기 시장

비뇨기 내시경 시장

전립선암 치료 기기 시장

요역동학 장비 시장

신루술 기기 시장

남성 생식 의료 시장

요도 가이드와이어 시장

ksm
영문 목차

영문목차

CAGR of 5.7%, reaching nearly $6.5 billion by the end of the forecast period.

The comprehensive report on the U.S. market for urological devices covers various segments, including urinary incontinence devices, stone management devices, benign prostate hyperplasia (BPH) treatment devices, urological endoscopes, prostate cancer treatment devices, urodynamic equipment, nephrostomy devices, men's reproductive health devices, and urinary guidewires.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends

10 Year Scope

Market Drivers & Limiters for Each Segment

Competitive Analysis with Market Shares for Each Segment

Recent Mergers & Acquisitions

Disease Overviews and Demographic Information

Company Profiles, Product Portfolios and SWOT for Top Competitors

As hospitals continue to expand their acquisitions of outpatient facilities and group purchasing organizations (GPOs) grow their influence, coupled with ongoing cuts in reimbursement rates in the urology sector, Average Selling Prices (ASPs) are likely to face ongoing pressure, potentially stifling future market growth.

Since its U.S. debut in 2013, NeoTract's UroLift(R) has seen rapid adoption among urologists for the treatment of Benign Prostatic Hyperplasia (BPH), mirroring its popularity in regions including Europe, Canada, and Australia. This minimally invasive procedure offers a quick recovery, enhancing its appeal. The 2017 acquisition of NeoTract by Teleflex has bolstered UroLift(R)'s market penetration, benefiting from Teleflex's extensive sales network. In September 2021, the launch of the UroLift Advanced Tissue Control (ATC)(R) and UroLift(R) 2 systems aimed to enhance patient safety and reduce logistical burdens, building on the original's clinical success.

MARKET SEGMENTATION SUMMARY

While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

Urinary Incontinence Devices Market - MedCore - The market for urinary incontinence treatments includes urinary catheters, urethral bulking agents, incontinence management devices, and urinary bags.

Stone Management Devices - MedCore - The total market for stone management devices includes ESWL capital equipment, ISWL equipment, Holmium lasers, Thulium lasers, stone fragment retrieval devices, ureteral stents, access sheaths.

BPH Treatment Devices - MedCore - The BPH treatment device market includes devices used for TURP, TUMT, TUNA, temporary prostatic stent, laser BPH, UroLift(R), Rezum(R) and iTind(R) procedures.

Urological Endoscope - MedCore - The urological endoscope market includes cystoscopes, ureteroscopes, resectoscopes and nephroscopes.

Prostate Cancer Treatment Devices - MedCore - The prostate cancer treatment device market includes brachytherapy devices, cryotherapy ablation devices, and hydrogel rectal spacers.

Urodynamic Equipment Market - MedCore - The market for urodynamic equipment includes urodynamic equipment and urodynamic consumables.

Nephrostomy Devices - MedCore - The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters and nephrostomy drainage tubes.

Men's Reproductive Health Market - MedCore - The total market for men's reproductive health treatment devices includes inflatable erectile dysfunction devices, malleable erectile dysfunction devices, vacuum assisted erectile dysfunction devices, and testicular implants.

Urinary Guidewire Market - MedCore - The market for guidewires includes all guidewires to be used in urological procedures CAGR of 5.7%, reaching nearly $6.5 billion by the end of the forecast period.

The comprehensive report on the U.S. market for urological devices covers various segments, including urinary incontinence devices, stone management devices, benign prostate hyperplasia (BPH) treatment devices, urological endoscopes, prostate cancer treatment devices, urodynamic equipment, nephrostomy devices, men's reproductive health devices, and urinary guidewires.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends

10 Year Scope

Market Drivers & Limiters for Each Segment

Competitive Analysis with Market Shares for Each Segment

Recent Mergers & Acquisitions

Disease Overviews and Demographic Information

Company Profiles, Product Portfolios and SWOT for Top Competitors

As hospitals continue to expand their acquisitions of outpatient facilities and group purchasing organizations (GPOs) grow their influence, coupled with ongoing cuts in reimbursement rates in the urology sector, Average Selling Prices (ASPs) are likely to face ongoing pressure, potentially stifling future market growth.

Since its U.S. debut in 2013, NeoTract's UroLift(R) has seen rapid adoption among urologists for the treatment of Benign Prostatic Hyperplasia (BPH), mirroring its popularity in regions including Europe, Canada, and Australia. This minimally invasive procedure offers a quick recovery, enhancing its appeal. The 2017 acquisition of NeoTract by Teleflex has bolstered UroLift(R)'s market penetration, benefiting from Teleflex's extensive sales network. In September 2021, the launch of the UroLift Advanced Tissue Control (ATC)(R) and UroLift(R) 2 systems aimed to enhance patient safety and reduce logistical burdens, building on the original's clinical success.

MARKET SEGMENTATION SUMMARY

While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

Urinary Incontinence Devices Market - MedCore - The market for urinary incontinence treatments includes urinary catheters, urethral bulking agents, incontinence management devices, and urinary bags.

Stone Management Devices - MedCore - The total market for stone management devices includes ESWL capital equipment, ISWL equipment, Holmium lasers, Thulium lasers, stone fragment retrieval devices, ureteral stents, access sheaths.

BPH Treatment Devices - MedCore - The BPH treatment device market includes devices used for TURP, TUMT, TUNA, temporary prostatic stent, laser BPH, UroLift(R), Rezum(R) and iTind(R) procedures.

Urological Endoscope - MedCore - The urological endoscope market includes cystoscopes, ureteroscopes, resectoscopes and nephroscopes.

Prostate Cancer Treatment Devices - MedCore - The prostate cancer treatment device market includes brachytherapy devices, cryotherapy ablation devices, and hydrogel rectal spacers.

Urodynamic Equipment Market - MedCore - The market for urodynamic equipment includes urodynamic equipment and urodynamic consumables.

Nephrostomy Devices - MedCore - The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters and nephrostomy drainage tubes.

Men's Reproductive Health Market - MedCore - The total market for men's reproductive health treatment devices includes inflatable erectile dysfunction devices, malleable erectile dysfunction devices, vacuum assisted erectile dysfunction devices, and testicular implants.

Urinary Guidewire Market - MedCore - The market for guidewires includes all guidewires to be used in urological procedures.

TABLE OF CONTENT

TABLE of CONTENTS

List of Figures

List of Charts

executive summary

U.S. Urological Device Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedure Included

Procedure Codes Investigated

Markets Included

Key Report Updates

Version History

research methodology

impact of covid-19 on THE U.S. Urological Device Market

Disease overview

Product Assessment

U.S. Urological Device Market Overview

Procedure Numbers

Urinary Incontinence Device Market

Stone Management Device Market

BPH Treatment Device Market

Urological Endoscope Market

Prostate Cancer Treatment Device Market

Urodynamic Equipment Market

Nephrostomy Device Market

Men's Reproductive Health Market

Urinary Guidewire Market

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기